De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant studyValentina Guarneri, PierFranco Conte, Giancarlo Bisagni et al.|Annals of Oncology|2019Cited by 97